127 related articles for article (PubMed ID: 31943253)
1. Nanoparticles containing β-cyclodextrin potentially useful for the treatment of Niemann-Pick C.
Donida B; Raabe M; Tauffner B; de Farias MA; Machado AZ; Timm F; Kessler RG; Hammerschmidt TG; Reinhardt LS; Brito VB; Portugal RV; Bernardi A; Frozza R; Moura DJ; Giugliani R; Poletto F; Vargas CR
J Inherit Metab Dis; 2020 May; 43(3):586-601. PubMed ID: 31943253
[TBL] [Abstract][Full Text] [Related]
2. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease.
Tamura A; Yui N
J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
[TBL] [Abstract][Full Text] [Related]
4. Evidence of redox imbalance and mitochondrial dysfunction in Niemann-Pick type C 1 patients: the in vitro effect of combined therapy with antioxidants and β-cyclodextrin nanoparticles.
Hammerschmidt TG; Donida B; Raabe M; Faverzani JL; de Fátima Lopes F; Machado AZ; Kessler RG; Reinhardt LS; Poletto F; Moura DJ; Vargas CR
Metab Brain Dis; 2023 Feb; 38(2):507-518. PubMed ID: 36447062
[TBL] [Abstract][Full Text] [Related]
5. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease.
Tamura A; Yui N
J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease.
Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T
Mol Genet Metab; 2016 Jul; 118(3):214-219. PubMed ID: 27184436
[TBL] [Abstract][Full Text] [Related]
7. Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann-Pick C1 mutant cell via lysosome-associated membrane protein 1.
Singhal A; Szente L; Hildreth JEK; Song B
Cell Death Dis; 2018 Oct; 9(10):1019. PubMed ID: 30282967
[TBL] [Abstract][Full Text] [Related]
8. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells.
Rosenbaum AI; Zhang G; Warren JD; Maxfield FR
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5477-82. PubMed ID: 20212119
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-Pick type C disease.
Tamura A; Yui N
Sci Rep; 2014 Mar; 4():4356. PubMed ID: 24619155
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in
Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132
[TBL] [Abstract][Full Text] [Related]
11. Analytical Characterization of Methyl-β-Cyclodextrin for Pharmacological Activity to Reduce Lysosomal Cholesterol Accumulation in Niemann-Pick Disease Type C1 Cells.
Li R; Hao J; Fujiwara H; Xu M; Yang S; Dai S; Long Y; Swaroop M; Li C; Vu M; Marugan JJ; Ory DS; Zheng W
Assay Drug Dev Technol; 2017; 15(4):154-166. PubMed ID: 28631941
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and evaluation of pluronic-based β-cyclodextrin polyrotaxanes for mobilization of accumulated cholesterol from Niemann-Pick type C fibroblasts.
Collins CJ; McCauliff LA; Hyun SH; Zhang Z; Paul LN; Kulkarni A; Zick K; Wirth M; Storch J; Thompson DH
Biochemistry; 2013 May; 52(19):3242-53. PubMed ID: 23560535
[TBL] [Abstract][Full Text] [Related]
13. Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann-Pick Type C Using Quantitative Proteomics.
Cougnoux A; Pergande MR; Serna-Perez F; Cologna SM
J Am Soc Mass Spectrom; 2023 Apr; 34(4):668-675. PubMed ID: 36920149
[TBL] [Abstract][Full Text] [Related]
14. Visualization of cholesterol deposits in lysosomes of Niemann-Pick type C fibroblasts using recombinant perfringolysin O.
Kwiatkowska K; Marszałek-Sadowska E; Traczyk G; Koprowski P; Musielak M; Lugowska A; Kulma M; Grzelczyk A; Sobota A
Orphanet J Rare Dis; 2014 Apr; 9():64. PubMed ID: 24775609
[TBL] [Abstract][Full Text] [Related]
15. Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C.
Yamada Y; Ishitsuka Y; Kondo Y; Nakahara S; Nishiyama A; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kamei S; Shuto T; Kai H; Hayashino Y; Sugita M; Kikuchi T; Hirata F; Miwa T; Takeda H; Orita Y; Seki T; Ohta T; Kurauchi Y; Katsuki H; Matsuo M; Higaki K; Ohno K; Matsumoto S; Era T; Irie T
Br J Pharmacol; 2021 Jul; 178(13):2727-2746. PubMed ID: 33782944
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin-Based Macromolecular Systems as Cholesterol-Mopping Therapeutic Agents in Niemann-Pick Disease Type C.
Puglisi A; Yagci Y
Macromol Rapid Commun; 2019 Jan; 40(1):e1800557. PubMed ID: 30216584
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrins applied to the treatment of lysosomal storage disorders.
Ishitsuka Y; Irie T; Matsuo M
Adv Drug Deliv Rev; 2022 Dec; 191():114617. PubMed ID: 36356931
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of the Anionic Hydroxypropyl-β-cyclodextrin:Poly(decamethylenephosphate) Polyrotaxane and Evaluation of its Cholesterol Efflux Potential in Niemann-Pick C1 Cells.
Egele K; Samaddar S; Schneider N; Thompson D; Wenz G
J Mater Chem B; 2019 Jan; 7(4):528-537. PubMed ID: 31372225
[TBL] [Abstract][Full Text] [Related]
19. Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.
Wehrmann ZT; Hulett TW; Huegel KL; Vaughan KT; Wiest O; Helquist P; Goodson H
PLoS One; 2012; 7(10):e48561. PubMed ID: 23144769
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).
Tortelli B; Fujiwara H; Bagel JH; Zhang J; Sidhu R; Jiang X; Yanjanin NM; Shankar RK; Carillo-Carasco N; Heiss J; Ottinger E; Porter FD; Schaffer JE; Vite CH; Ory DS
Hum Mol Genet; 2014 Nov; 23(22):6022-33. PubMed ID: 24964810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
